NO20003677D0 - Langvarig frigivelses tigabim formuleringer med reduserte bivirkninger - Google Patents

Langvarig frigivelses tigabim formuleringer med reduserte bivirkninger

Info

Publication number
NO20003677D0
NO20003677D0 NO20003677A NO20003677A NO20003677D0 NO 20003677 D0 NO20003677 D0 NO 20003677D0 NO 20003677 A NO20003677 A NO 20003677A NO 20003677 A NO20003677 A NO 20003677A NO 20003677 D0 NO20003677 D0 NO 20003677D0
Authority
NO
Norway
Prior art keywords
tigabim
formulations
side effects
prolonged release
reduced side
Prior art date
Application number
NO20003677A
Other languages
English (en)
Other versions
NO20003677L (no
Inventor
Francisco J Alvarez
Russel T Slade
Kathleen M Apfelbaum
David M Brown
Linda E Gustavson
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20003677D0 publication Critical patent/NO20003677D0/no
Publication of NO20003677L publication Critical patent/NO20003677L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20003677A 1998-01-22 2000-07-18 Langvarig frigivelses tiagabin formuleringer med reduserte bivirkninger NO20003677L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7213098P 1998-01-22 1998-01-22
PCT/US1999/001242 WO1999037302A1 (en) 1998-01-22 1999-01-22 Extended release tiagabine formulations with reduced side-effects

Publications (2)

Publication Number Publication Date
NO20003677D0 true NO20003677D0 (no) 2000-07-18
NO20003677L NO20003677L (no) 2000-09-20

Family

ID=22105780

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003677A NO20003677L (no) 1998-01-22 2000-07-18 Langvarig frigivelses tiagabin formuleringer med reduserte bivirkninger

Country Status (23)

Country Link
US (1) US20070053980A1 (no)
EP (1) EP1049470B1 (no)
JP (1) JP2002501022A (no)
KR (1) KR20010034313A (no)
CN (1) CN1145484C (no)
AR (1) AR018041A1 (no)
AT (1) ATE350035T1 (no)
AU (1) AU2239599A (no)
BG (1) BG104692A (no)
CA (1) CA2318448A1 (no)
CO (1) CO4970814A1 (no)
DE (1) DE69934670D1 (no)
HU (1) HUP0101739A3 (no)
IL (1) IL137324A0 (no)
NO (1) NO20003677L (no)
NZ (1) NZ505725A (no)
PL (1) PL194595B1 (no)
SA (1) SA99200204B1 (no)
SK (1) SK11072000A3 (no)
TR (2) TR200505223T2 (no)
TW (1) TW585787B (no)
WO (1) WO1999037302A1 (no)
ZA (1) ZA99407B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872734B2 (en) 2000-10-20 2005-03-29 Abbott Laboratories Use of tiagabine for treatment of diabetic neuropathy and migraine
KR100510270B1 (ko) * 2002-11-29 2005-08-26 센츄론(주) 펠렛타이저를 이용한 서방성 제제의 제조방법
CN102908327B (zh) * 2011-08-05 2015-03-11 江苏恒瑞医药股份有限公司 伊伐布雷定或其可药用盐的缓释制剂
KR102051132B1 (ko) * 2017-03-17 2019-12-02 주식회사 종근당 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
US5126145A (en) * 1989-04-13 1992-06-30 Upsher Smith Laboratories Inc Controlled release tablet containing water soluble medicament
US5273758A (en) * 1991-03-18 1993-12-28 Sandoz Ltd. Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
CZ292256B6 (cs) * 1995-05-05 2003-08-13 Novo Nordisk A/S Farmaceutická směs a způsob její přípravy
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
ATE212550T1 (de) * 1997-08-01 2002-02-15 Elan Corp Plc Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
US5843477A (en) * 1997-09-30 1998-12-01 Bayer Corporation Lubricants for use in tabletting

Also Published As

Publication number Publication date
BG104692A (en) 2001-05-31
WO1999037302A1 (en) 1999-07-29
CO4970814A1 (es) 2000-11-07
DE69934670D1 (de) 2007-02-15
PL342767A1 (en) 2001-07-02
CN1145484C (zh) 2004-04-14
KR20010034313A (ko) 2001-04-25
HUP0101739A2 (hu) 2002-03-28
EP1049470B1 (en) 2007-01-03
SK11072000A3 (sk) 2001-01-18
NZ505725A (en) 2003-01-31
ZA99407B (en) 1999-07-20
TR200505223T2 (tr) 2006-04-21
ATE350035T1 (de) 2007-01-15
HUP0101739A3 (en) 2002-10-28
AR018041A1 (es) 2001-10-31
SA99200204B1 (ar) 2006-10-11
AU2239599A (en) 1999-08-09
IL137324A0 (en) 2001-07-24
NO20003677L (no) 2000-09-20
TR200002102T2 (tr) 2000-12-21
CA2318448A1 (en) 1999-07-29
JP2002501022A (ja) 2002-01-15
US20070053980A1 (en) 2007-03-08
EP1049470A1 (en) 2000-11-08
TW585787B (en) 2004-05-01
PL194595B1 (pl) 2007-06-29
CN1293571A (zh) 2001-05-02

Similar Documents

Publication Publication Date Title
DK0973527T3 (da) Clarithromycinformuleringer med forlænget frigivelse
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
NO20004240L (no) Formuleringer
ATE224703T1 (de) Brauseformulierungen
DK1096937T3 (da) Ranolazinformuleringer med langvarig frigivelse
PT1130966E (pt) Formulacoes antiparasitarias
DK0922386T3 (da) Sammensætninger med reguleret frigivelse
DE69805443D1 (de) Sachet-formulierungen
MA24473A1 (fr) Formulations
ATE227074T1 (de) Mikrokapsel-formulierungen
ATE254907T1 (de) Natriumhydrogendivalproat-formulierungen mit gesteuerter freigabe
DK0880892T5 (da) Midler med reguleret frigivelse
NO20002126L (no) Formulering med forlenget frigjøring
IS6398A (is) Lyfjablöndur
DE69935609D1 (de) Formulierungen enthaltend cefuroxim-axetil
ATE232683T1 (de) Mikrokapsel-formulierungen
NO20005722L (no) Brusetilberedninger
NO20021452D0 (no) Orale kontrollerte frigivelsesformuleringer
NO20003677L (no) Langvarig frigivelses tiagabin formuleringer med reduserte bivirkninger
NO971030D0 (no) Preparat med langvarig frigjöring
SE9800166D0 (sv) Lyftdon med snabblås
FI982340A0 (fi) Suksiside
SE9802667D0 (sv) Snabbkoppling

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application